Castle Creek Biosciences: Funding, Investors & Team (Sep 2026)
Castle Creek Biosciences is focused on developing and commercializing novel, personalized gene therapies for rare skin and connective tissue disorders with high unmet need. It was founded in 2015 and headquartered in Pennsylvania, United States.
Castle Creek Biosciences has raised $115M across 2 funding rounds on record, the most recent an undisclosed round of $113M announced in May 2022.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Castle Creek Biosciences Company Profile and Key Stats
Latest funding round on record: May 2022.
Castle Creek Biosciences Funding Rounds
Castle Creek Biosciences raised $1.8M in a Grant announced in Oct 2021.
7 months later, an undisclosed round of $113M was announced in May 2022.
Castle Creek Biosciences Founders and Leadership Team
Contact details for the Castle Creek Biosciences team: 1 of 1 has an email address on file.
Start 14-day free trial →Castle Creek Biosciences Funding Compared to Other Biotechnology Startups
Castle Creek Biosciences' latest round of $113M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Castle Creek Biosciences in Biotechnology and Exton
Companies Similar to Castle Creek Biosciences
SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…
DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…
Solstice Oncology is a clinical stage immuno-oncology company
Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…
BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Castle Creek Biosciences Funding FAQs
What does Castle Creek Biosciences do?
Castle Creek Biosciences is focused on developing and commercializing novel, personalized gene therapies for rare skin and connective tissue disorders with high unmet need. It was founded in 2015 and headquartered in Pennsylvania, United States.
How much funding has Castle Creek Biosciences raised?
Castle Creek Biosciences has raised $115M across 2 rounds on record. The most recent is an undisclosed round of $113M announced in May 2022.
When did Castle Creek Biosciences last raise funding?
Castle Creek Biosciences' most recent funding round on record is an undisclosed round of $113M, announced in May 2022.
Who is the CEO of Castle Creek Biosciences?
Matthew Gantz is listed as CEO at Castle Creek Biosciences.
Where is Castle Creek Biosciences headquartered?
Castle Creek Biosciences is based in Exton, Pennsylvania, United States.
How many employees does Castle Creek Biosciences have?
Castle Creek Biosciences is in the 11-50 employee band.
How does Castle Creek Biosciences' funding compare to other Biotechnology startups?
Castle Creek Biosciences' latest round of $113M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.
About FundedIQ's Castle Creek Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Castle Creek Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.